(%)
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
Market is Open
Last quote from:
After-Hours Quote
Market is closed for
(%)
After-Hours Quote is Unavailable
- Ownership
-
Shuttle Pharmaceuticals Holdings, Inc. Insider Trading
* In original currency USD
Loading Data
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price | Total Amount |
---|---|---|---|---|---|---|---|---|
Tuesday, March 11th, 2025 | Cooper Chris | officer | 0 | 0 | 0.00 USD | 0 USD | ||
Friday, February 28th, 2025 | Scorsis George | director | 184,162 | 0 | 0.00 USD | 0 USD | ||
Friday, February 28th, 2025 | Tung Joseph | director | 184,162 | 0 | 0.00 USD | 0 USD | ||
Friday, February 28th, 2025 | Nabyt Oleh | director | 184,162 | 0 | 0.00 USD | 0 USD | ||
Tuesday, December 31st, 2024 | Brown Milton | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Tuesday, December 31st, 2024 | Schafer Joshua | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Tuesday, December 31st, 2024 | Richards Steven M | director: | 0 | 0 | 0.00 USD | 0 USD | ||
Wednesday, May 1st, 2024 | Jung Mira | officer: Chief Scientific Officer | 135,715 | A-Award | D | 598 | 11.28 USD | 6,745 USD |
Thursday, June 13th, 2024 | Lorber Timothy J. | officer: Chief Financial Officer | 227,635 | D | 0 | 0.00 USD | 0 USD | |
Thursday, December 29th, 2022 | Senanayake Chris | director | 2,791 | S-Sale | D | 1,626 | 1.61 USD | 2,610 USD |
Friday, March 8th, 2024 | Vander Hoek Michael | officer: Chief Financial Officer | 103,852 | A-Award | A | 100,000 | 0.00 USD | 0 USD |
Wednesday, December 13th, 2023 | Brown Milton | director | 1,094,610 | S-Sale | D | 2,921 | 0.46 USD | 1,353 USD |
Wednesday, December 13th, 2023 | Jacobs Bette | director | 27,064 | S-Sale | D | 4,157 | 0.46 USD | 1,926 USD |
Monday, August 14th, 2023 | Dritschilo Anatoly | director, 10 percent owner, officer: CEO and Chairman | 2,100,000 | G-Gift | A | 2,100,000 | 0.00 USD | 0 USD |
Monday, August 14th, 2023 | Dritschilo Anatoly | director, 10 percent owner, officer: CEO and Chairman | 1,104,407 | G-Gift | D | 2,100,000 | 0.00 USD | 0 USD |
Wednesday, February 15th, 2023 | Brown Milton | director | 25,000 | A-Award | A | 25,000 | 1.92 USD | 48,000 USD |
Thursday, December 29th, 2022 | Richards Steven M | director | 1,707 | S-Sale | D | 995 | 1.61 USD | 1,597 USD |
Thursday, December 29th, 2022 | Adkins William | director | 184,071 | S-Sale | D | 995 | 1.61 USD | 1,597 USD |
Friday, September 2nd, 2022 | Adkins William | director | 138,889 | J-Other | A | 138,889 | 0.00 USD | 0 USD |
Thursday, December 29th, 2022 | Brown Milton | director | 1,072,531 | S-Sale | D | 995 | 1.61 USD | 1,597 USD |
Thursday, December 29th, 2022 | Dritschilo Anatoly | officer: CEO and Chairman | 1,085,200 | S-Sale | D | 8,372 | 1.61 USD | 13,437 USD |
Thursday, December 29th, 2022 | Rich Tyvin | officer: Chief Medical Officer | 2,429 | S-Sale | D | 1,414 | 1.61 USD | 2,270 USD |
Thursday, December 29th, 2022 | Jung Mira | officer: Chief Scientific Officer | 1,071,388 | S-Sale | D | 328 | 1.61 USD | 526 USD |
Thursday, December 29th, 2022 | Jacobs Bette | director | 31,221 | S-Sale | D | 4,366 | 1.61 USD | 7,007 USD |
Thursday, December 29th, 2022 | Dritschilo Peter | officer: President and COO | 6,560 | S-Sale | D | 3,820 | 1.61 USD | 6,131 USD |
Thursday, December 29th, 2022 | Vander Hoek Michael | officer: Chief Financial Officer | 3,852 | S-Sale | D | 2,243 | 1.61 USD | 3,600 USD |
Friday, October 28th, 2022 | Jacobs Bette | director | 35,587 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Brown Milton | director | 1,073,526 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Dritschilo Anatoly | director, 10 percent owner, officer: CEO and Chairman | 1,093,572 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Richards Steven M | director | 2,702 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Senanayake Chris | director | 3,843 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Adkins William | director | 280,480 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Rich Tyvin | officer: Chief Medical Officer | 3,843 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Dritschilo Peter | officer: President and COO | 10,380 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Jung Mira | officer: Chief Scientific Officer | 1,071,716 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Vander Hoek Michael | officer: Chief Financial Officer | 6,095 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Schafer Joshua | director | 2,702 | D | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Dritschilo Anatoly | director, 10 percent owner, officer: CEO and Chairman | 3,204,407 | I | 0 | 0.00 USD | 0 USD | |
Monday, August 29th, 2022 | Dritschilo Anatoly | director, 10 percent owner, officer: CEO and Chairman | 1,070,824 | D | 0 | 0.00 USD | 0 USD |